Table 3. Multiple logistic regression analysis of clinical baseline variables in clinically isolated syndrome and multiple sclerosis patients (n = 70).
| Independent variable | OR | 95% CI | p |
|---|---|---|---|
| Time to TPE | 0.994 | 0.977–1.011 | 0.485 |
| DMD before TPE | 0.419 | 0.085–2.072 | 0.286 |
| Gd + lesions in MRI before TPE | 0.095 | 0.019–0.479 | 0.004 |
| Number of relapses before TPE | 1.093 | 0.915–1.306 | 0.325 |
| EDSS before TPE | 0.95 | 0.616–1.466 | 0.815 |
| Cumulative MP dose before TPE | 0.647 | 0.259–1.617 | 0.352 |
| Time to GCS treatment before TPE | 1.042 | 0.995–1.092 | 0.082 |
| Worsening during GCS treatment | 0.391 | 0.066–2.325 | 0.302 |
CIS = clinically isolated syndrome, DMD = disease modifying drug, EDSS = expanded disability status scale, GCS = glucocorticosteroid, Gd+ = gadolineum contrast medium enhancement, MP = methylprednisolone, MRI = magnetic resonance imaging, MS = multiple sclerosis, TPE = therapeutic plasma exchange.